A report from The Huffington Post details 2breathe Technologies, a new technology that incorporates a small sensor and a smartphone app to detect breathing and induce sleep.
Gavish and his father, Dr. Benjamin Gavish, are pioneers in the digital therapeutic device field, first in hypertension and now in sleep. The elder Gavish invented the technology.
The company’s original product, RESPeRATE, is the world’s only FDA-cleared, non-invasive hypertension treatment device. Used by hundreds of thousands of patients, RESPeRATE is featured by its brand name in the American Heart Association statement about non-pharmacological treatments for high blood pressure.